Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $14,424 - $17,102
-310 Reduced 6.9%
4,182 $219,000
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $63,821 - $79,082
-1,395 Reduced 23.7%
4,492 $233,000
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $63,821 - $79,082
1,395 Added 31.06%
5,887 $213,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $185,609 - $275,135
4,492 New
4,492 $265,000
Q3 2021

Nov 03, 2021

SELL
$39.25 - $50.42 $228,121 - $293,041
-5,812 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$35.91 - $40.68 $2,693 - $3,051
-75 Reduced 1.27%
5,812 $228,000
Q1 2021

May 10, 2021

BUY
$33.49 - $37.77 $3,148 - $3,550
94 Added 1.62%
5,887 $213,000
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $193,891 - $246,550
5,793 New
5,793 $213,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bluesphere Advisors, LLC Portfolio

Follow Bluesphere Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluesphere Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluesphere Advisors, LLC with notifications on news.